Literature DB >> 7980470

Beta 3-adrenoceptor agonist-induced down-regulation of Gs alpha and functional desensitization in a Chinese hamster ovary cell line expressing a beta 3-adrenoceptor refractory to down-regulation.

J Chambers1, J Park, D Cronk, C Chapman, F R Kennedy, S Wilson, G Milligan.   

Abstract

Chinese hamster ovary (CHO) cells transfected to express human beta 2- or beta 3-adrenoceptors (beta 2-CHO and beta 3-CHO cells) were exposed to the beta-adrenoceptor agonist isoprenaline at various concentrations and for differing times. Sustained exposure of the beta 2-CHO but not beta 3-CHO cells to isoprenaline resulted in a time- and concentration-dependent down-regulation of the receptor as measured by a reduction in specific binding of [125I]cyanopindolol. Such maintained exposure of cells expressing either receptor to the agonist produced a marked down-regulation of immunologically detectable levels of the alpha subunit of the stimulatory guanine-nucleotide-binding protein Gs. This effect was specific for Gs because levels of both G12 alpha and Gq alpha/G11 alpha were unaltered by isoprenaline treatment of both beta 2-CHO and beta 3-CHO cells. The effect of isoprenaline on Gs alpha down-regulation was some 30-fold more potent in the beta 2-CHO than in the beta 3-CHO cells. Time courses of isoprenaline-induced down-regulation of Gs alpha were not different, however, in the two cell lines. Isoprenaline treatment of the beta 3-CHO cells produced a desensitization of agonist-mediated regulation of adenylyl cyclase, manifested by a 4-fold reduction in the potency and a 30% reduction in maximal effect of the agonist, whereas desensitization of the beta 2-CHO cells was considerably greater (25-fold reduction in potency and 70% reduction in maximal effect). These results demonstrate that agonist-induced down-regulation of the G-protein which interacts with a receptor can be produced by both beta 2- and beta 3-adrenoceptors. Despite apparent concurrence of down-regulation of receptors and G-proteins in other systems [e.g. Adie, Mullaney, McKenzie and Milligan (1992) Biochem. J. 285, 529-536], agonist-induced receptor down-regulation does not appear to be a prerequisite for down-regulation of the G-protein. Furthermore, the results suggest that agonist-induced down-regulation of a G-protein may be sufficient, in the absence of receptor regulation, to induce some agonist desensitization of effector function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980470      PMCID: PMC1137641          DOI: 10.1042/bj3030973

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Widespread distribution of Gq alpha/G11 alpha detected immunologically by an antipeptide antiserum directed against the predicted C-terminal decapeptide.

Authors:  F M Mitchell; I Mullaney; P P Godfrey; S J Arkinstall; M J Wakelam; G Milligan
Journal:  FEBS Lett       Date:  1991-08-05       Impact factor: 4.124

2.  Down-regulation of Gi sub-types by prolonged incubation of adipocytes with an A1 adenosine receptor agonist.

Authors:  A Green; J L Johnson; G Milligan
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

3.  Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.

Authors:  F R McKenzie; G Milligan
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Molecular characterization of the human beta 3-adrenergic receptor.

Authors:  L J Emorine; S Marullo; M M Briend-Sutren; G Patey; K Tate; C Delavier-Klutchko; A D Strosberg
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

Review 6.  Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications.

Authors:  G Milligan
Journal:  Trends Pharmacol Sci       Date:  1993-11       Impact factor: 14.819

7.  Prostaglandin E1-mediated, cyclic AMP-independent, down-regulation of Gs alpha in neuroblastoma x glioma hybrid cells.

Authors:  F R McKenzie; G Milligan
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

8.  Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.

Authors:  M Valiquette; H Bonin; M Hnatowich; M G Caron; R J Lefkowitz; M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.

Authors:  P T Campbell; M Hnatowich; B F O'Dowd; M G Caron; R J Lefkowitz; W P Hausdorff
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

10.  Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells.

Authors:  K M Tate; M M Briend-Sutren; L J Emorine; C Delavier-Klutchko; S Marullo; A D Strosberg
Journal:  Eur J Biochem       Date:  1991-03-14
View more
  7 in total

Review 1.  Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Authors:  Katerina Okeke; Stephane Angers; Michel Bouvier; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 2.  Upregulation of β3-adrenoceptors-a general marker of and protective mechanism against hypoxia?

Authors:  Massimo Dal Monte; Bronwyn A Evans; Ebru Arioglu-Inan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-18       Impact factor: 3.000

3.  Cold-induced reduction in Gi alpha proteins in brown adipose tissue. Effects on the cellular hypersensitization to noradrenaline caused by pertussis-toxin treatment.

Authors:  P Svoboda; L Unelius; A Dicker; B Cannon; G Milligan; J Nedergaard
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

4.  Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-10       Impact factor: 3.000

5.  (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.

Authors:  C Rouget; M Breuiller-Fouché; F J Mercier; M J Leroy; C Loustalot; E Naline; R Frydman; T Croci; E J Morcillo; C Advenier; M Bardou
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

7.  Agonist-induced desensitization of human β3-adrenoceptors expressed in human embryonic kidney cells.

Authors:  Martina B Michel-Reher; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-12       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.